Business / Finance RSS Feed - Business / Finance

TGen and Baylor partnership set to increase treatment options for cancer patients

TGen and Baylor partnership set to increase treatment options for cancer patients

The Translational Genomics Research Institute (TGen) and Baylor Research Institute (BRI) at Dallas today announce an agreement that will focus on accelerating early detection and treatments for patients with a broad range of cancers. [More]
Merus Labs International acquires rights to manufacture, market specialty pharmaceutical products in multiple countries

Merus Labs International acquires rights to manufacture, market specialty pharmaceutical products in multiple countries

Merus Labs International Inc. is pleased to announce that one of its wholly owned subsidiaries has signed a definitive agreement to acquire the rights to manufacture, market, and sell two established specialty pharmaceutical products in certain European and other markets. [More]

Industry leaders meet at Frost & Sullivan's GIL 2015: Europe in London to learn, share new strategies for innovation

Between 2012 and 2014, over 70 companies globally valued at more than $1 billion were start-ups with new business models that were unique and transformative. During the same period, most business model innovators have managed to produce consistently profitable returns with average revenue gain between 100 and 500 percent. The keys to these success stories have been connectivity and convergence with 50 percent of new start-ups launched on mobile platforms. [More]
Hope For Heroes Foundation forms national alliance with USA Medical Card

Hope For Heroes Foundation forms national alliance with USA Medical Card

Hope For Heroes Foundation today announced the formation of a groundbreaking national alliance with USA Medical Card, a leading provider of free pharmacy discount cards. The new nationwide initiative benefiting Hope For Heroes will help fund programs that empower independence for our nation's disabled military veterans, police, firemen, and EMS professionals, and will help more people afford their prescriptions. [More]

ABRY Partners signs definitive agreement to acquire FastMed Urgent Care

ABRY Partners, a leading private equity firm, today announced that it has entered into a definitive agreement to acquire FastMed Urgent Care, the second largest independent urgent care organization in the U.S. and the largest network in both North Carolina and Arizona. The transaction is expected to close in the second quarter. [More]
CVS Health enters into definitive agreement to acquire Omnicare

CVS Health enters into definitive agreement to acquire Omnicare

CVS Health Corporation and Omnicare, Inc. announced today that they have entered into a definitive agreement for CVS Health to acquire Omnicare, the leading provider of pharmacy services to long term care facilities, for $98.00 per share in cash, for a total enterprise value of approximately $12.7 billion, which includes approximately $2.3 billion in debt. [More]

Banook Group consolidates three subsidiaries under one unique name and brand

Banook Group, an international provider of cardiac safety, central imaging and endpoint adjudication services, today announces that its three subsidiaries will now be combined into one unique name and brand. [More]
Enterprise Therapeutics secures additional funding to accelerate drug discovery for treatment of respiratory diseases

Enterprise Therapeutics secures additional funding to accelerate drug discovery for treatment of respiratory diseases

ENTERPRISE THERAPEUTICS Ltd, a drug discovery company focused on new therapeutics for respiratory diseases, today announced that it has secured an additional £2.4m ($3.6m) in Series-A financing. [More]

In-house training solutions from PTI: save time and cost in upskilling staff

With course topics that include, but aren’t limited to, business strategy, clinical trials, manufacturing, R&D and regulatory affairs, PTI covers all aspects of the drug and device development lifecycle... [More]
Dolomite’s microfluidics technology ideal for B cell encapsulation

Dolomite’s microfluidics technology ideal for B cell encapsulation

A Dolomite droplet generation system is helping researchers at Weill Cornell Medical College in New York, USA, to encapsulate human and mouse B cells for the cloning of antibody genes.. [More]
UK Medical Device Companies in the Spotlight at the Medilink UK Awards 2015

UK Medical Device Companies in the Spotlight at the Medilink UK Awards 2015

News-Medical.net was proud to sponsor this year’s Medilink UK Innovation Award. The Innovation Award was presented to The Learning Clinic for their VitalPAC Nurse software platform which is used to capture patient observations in real time... [More]

DWHP announces sale of Health & Safety Institute to Riverside

DW Healthcare Partners, a healthcare-focused private equity, announced the sale of its portfolio company, Health & Safety Institute, Inc., to The Riverside Company, a New York-based private equity firm. The terms of the transaction were not disclosed. [More]
DNAtrix signs agreement to utilize Alcyone's MEMS platform for direct drug delivery into glioblastoma

DNAtrix signs agreement to utilize Alcyone's MEMS platform for direct drug delivery into glioblastoma

Alcyone Lifesciences, Inc., a leader in neural intervention systems for neurological conditions and targeted drug delivery, and DNAtrix Inc., a privately held biotechnology company and a leader in oncolytic virus therapy, have entered into an exclusive clinical collaboration. Under the agreement, DNAtrix will utilize Alcyone's MEMS Cannula (AMC) targeted delivery platform for the intratumoral delivery of DNX-2401, an oncolytic adenovirus and DNAtrix's lead product for the treatment of the most aggressive form of brain cancer, glioblastoma (GBM). [More]
OrthoSpace announces completion of financing transaction

OrthoSpace announces completion of financing transaction

OrthoSpace Ltd. announced today the completion of a financing transaction led by HealthpointCapital, LLC, which also includes existing investors Smith & Nephew and TriVentures. [More]
ORIG3N, LabCorp form strategic partnership

ORIG3N, LabCorp form strategic partnership

ORIG3N, Inc., a pioneer in regenerative medicine and provider of induced pluripotent stem cell (iPSC) storage, called LifeCapsule, today announced a strategic collaboration with Laboratory Corporation of America Holdings. [More]
U.K Ophthalmologists lead in treatment of wet AMD patients with Oraya therapy across europe

U.K Ophthalmologists lead in treatment of wet AMD patients with Oraya therapy across europe

Oraya Therapy was introduced first in the U.K., followed by Switzerland and Germany. The therapy is intended as a one-time, non-invasive treatment that maintains vision with fewer anti-vascular endothelial growth factor (anti-VEGF) injections into the eye... [More]

University of Denver Announces Dual Law/Healthcare Degree

The University of Denver now offers a dual degree between the Sturm College of Law and University College, where students may earn a Juris Doctor and Master of Science in Healthcare Leadership... [More]
Cryoport net revenues increase 44% to $1.2 million in fourth quarter 2015

Cryoport net revenues increase 44% to $1.2 million in fourth quarter 2015

Cryoport, Inc. today announced financial results for the three and twelve-month periods ended March 31, 2015. [More]
BioNTech, Genmab to jointly develop and commercialize immunomodulatory antibodies for cancer

BioNTech, Genmab to jointly develop and commercialize immunomodulatory antibodies for cancer

BioNTech AG, a fully integrated biotechnology company developing truly personalized cancer immunotherapies, announces that it has signed an agreement with Genmab A/S to jointly research, develop and commercialize multiple bispecific antibodies for cancer immunotherapy using proprietary technologies from both companies: BioNTech's proprietary immunomodulatory antibodies and Genmab's DuoBody technology platform. [More]
Linkam and Cambridge IVF work on the development of new protocols for sperm testing

Linkam and Cambridge IVF work on the development of new protocols for sperm testing

IVF is becoming increasingly important as fertility and birth rates fall in developed countries. Ensuring patients get the right treatment is important both from an emotional and financial perspective... [More]
Advertisement
Advertisement